A proliferation analysis of arterial neointimal hyperplasia: lessons for antiproliferative restenosis therapies.

[1]  M. Ferguson,et al.  Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy. , 1993, Circulation research.

[2]  J. Isner,et al.  Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization. , 1993, The Journal of clinical investigation.

[3]  E J Topol,et al.  The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. , 1992, Journal of the American College of Cardiology.

[4]  Ward Casscells,et al.  Migration of Smooth Muscle and Endothelial Cells: Critical Events in Restenosis , 1992, Circulation.

[5]  Lippincott Williams Wilkins,et al.  Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angiopla , 1992, Circulation.

[6]  J. O’Keefe,et al.  Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty. , 1992, Journal of the American College of Cardiology.

[7]  R E Vlietstra,et al.  Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. , 1992, Journal of the American College of Cardiology.

[8]  R. Kandolf,et al.  Migratory Activity of Human Smooth Muscle Cells Cultivated From Coronary and Peripheral Primary and Restenotic Lesions Removed by Percutaneous Atherectomy , 1992, Circulation.

[9]  P. Serruys,et al.  Restenosis after percutaneous transluminal coronary angioplasty. , 1992, Herz.

[10]  S. Schwartz,et al.  Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. , 1992, The Journal of clinical investigation.

[11]  M. Stanley,et al.  Cytologic assessment of tumor cell kinetics: Applications of monoclonal antibody Ki‐67 to fine‐needle aspiration smears , 1991, Diagnostic cytopathology.

[12]  H. Stein,et al.  Proliferative pattern of head and neck cancer. , 1991, American journal of surgery.

[13]  M. Reidy,et al.  Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF , 1991, Science.

[14]  R. Warnke,et al.  Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling. , 1991, The American journal of pathology.

[15]  C. Barone,et al.  Cell kinetics of gastrointestinal tumors after different nutritional regimens. A preliminary report. , 1991, Journal of clinical gastroenterology.

[16]  V. Fuster,et al.  Importance of antithrombin therapy during coronary angioplasty. , 1991, Journal of the American College of Cardiology.

[17]  S. Schwartz,et al.  Methodologic considerations important in the accurate quantitation of aortic smooth muscle cell replication in the normal rat. , 1991, The American journal of pathology.

[18]  S. Schwartz,et al.  Cell proliferation in human coronary arteries. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Spencer B. King,et al.  Restenosis After Coronary Angioplasty: Potential Biologic Determinants and Role of Intimal Hyperplasia , 1989 .

[20]  M. Reidy,et al.  Kinetics of cellular proliferation after arterial injury. V. Role of acute distension in the induction of smooth muscle proliferation. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[21]  P W Serruys,et al.  Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. , 1988, Circulation.

[22]  V. Fuster,et al.  Deep arterial injury during experimental angioplasty: relation to a positive indium-111-labeled platelet scintigram, quantitative platelet deposition and mural thrombosis. , 1986, Journal of the American College of Cardiology.

[23]  M. Reidy,et al.  Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[24]  S. Schwartz,et al.  Significance of Quiescent Smooth Muscle Migration in the Injured Rat Carotid Artery , 1985, Circulation research.

[25]  M. Reidy,et al.  Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[26]  M. Reidy,et al.  Mechanisms of stenosis after arterial injury. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[27]  G. Thorgeirsson,et al.  Migration of human vascular endothelial and smooth muscle cells. , 1979, Laboratory investigation; a journal of technical methods and pathology.

[28]  S. Shackney,et al.  Correlations between the DNA content distribution and tritiated thymidine studies in relation to population size in sarcoma 180 in vitro. , 1974, Cancer research.

[29]  A. K. Laird.  Dynamics of Tumour Growth , 1964, British Journal of Cancer.

[30]  W. Edwards,et al.  Developmental stages of restenotic neointimal hyperplasia following porcine coronary artery injury: A morphologic review , 1993 .

[31]  G. Mazzini,et al.  Proliferating cell nuclear antigen (PCNA)/cyclin expression during the cell cycle in normal and leukemic cells. , 1991, Leukemia research.

[32]  O. Iversen.  The cell kinetics of the inflammatory reaction. Introduction and overview. , 1989, Current topics in pathology. Ergebnisse der Pathologie.

[33]  M. Nobuyoshi,et al.  Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. , 1988, Journal of the American College of Cardiology.

[34]  Horny Hp,et al.  Proliferation of invasive breast carcinomas and colorectal adenocarcinomas: an immunohistochemical in situ investigation with the monoclonal antibody Ki-67. , 1988 .

[35]  B. Chabner.  Pharmacologic principles of cancer treatment , 1982 .